PolyPid

4.36
Open
4.36
Market Cap
83.78M+
High
4.42
Low
4.33
Close
4.39
Volume
54.26K+
P/E Ratio
-2.10
Div/Yield
0.00%

About PolyPid

PolyPid Ltd. 是一家後期生物製藥公司,開發、製造和商業化基於聚合物-脂質包封基質 (PLEX) 平台的產品,以滿足未滿足的醫療需求。其主要候選產品是 D-PLEX100,該藥物正在進行 III 期臨床試驗,用於預防胸骨(骨骼)手術部位感染(SSI)以及預防腹部(軟組織)SSI。 PolyPid Ltd. 成立於 2008 年,總部位於以色列佩塔提克瓦。

如何購買 PolyPid (PYPD)

登入
1分鐘開戶

1分鐘開戶

僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助,支援 RockFlow App 和網頁端操作。

充值資金

充值資金

帳戶驗證完成後,您可以使用首選的支付方式向帳戶充值。

購買 PYPD

購買 PYPD

透過 RockFlow App 或網頁端搜尋 PYPD,輸入您想要投資的金額,然後點擊確認即可完成交易。

logo

Social

Download

google playapp store

© Rockalpha Limited. All Rights Reserved.

Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.